Gå ubegrenset med Magzter GOLD

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99
 
$74.99/År

Prøve GULL - Gratis

There's crushing news for people who want to live long

Mint New Delhi

|

April 21, 2025

A wonder drug that a wealthy longevity seeker was testing on himself may have turned out to be a dud

- MANU JOSEPH

A few days ago, Bryan Johnson, a centi-millionaire who has spent millions on reversing ageing—especially his own—posted some bad news for humanity on his YouTube channel. Rapamycin, which for a long time has been the most promising molecule in our quest to prolong youth, was not making him younger; instead, it was "accelerating" his ageing.

Johnson, who is 47 and looks 46, conducts various experiments on himself in his effort to live like a young man for a very long time. I am counting on him. His food consumption is so calibrated that he knows the number of calories he has gulped. He does not eat after 11 am, unless he has to meet people socially and must eat at ungodly hours like 7 pm just to shut them up. He sleeps around 8:30 pm, alone. I know he has high standards for himself because he recently visited Delhi, probably out of ignorance, and refused to breathe the air for too long. Among the most important things he was performing on himself was taking small quantities of rapamycin, a drug that is chiefly used to prevent the body's rejection of organ transplants. It does not have approval as an anti-ageing drug, though it is widely believed to have potential for that. The compound had extended the lifespan of mice and worms beyond ambiguity, and of other animals, too. Johnson was its most famous human test subject.

FLERE HISTORIER FRA Mint New Delhi

Mint New Delhi

Mint New Delhi

US energy giants eye India LNG network

US energy giants Exxon-Mobil Corp. and Chevron Corp. are eying entry into India's LNG infrastructure business, including terminals and pipelines, said two people in the know, even as the two nations look to thrash out differences over New Delhi's Russian oil imports.

time to read

3 mins

October 01, 2025

Mint New Delhi

Mint New Delhi

Will Tata Steel's Dutch pact help cut its emissions?

Tata Steel signed a pact with the Netherlands government on Monday to receive up to €2 billion aid to cut emissions at its Dutch facility.

time to read

2 mins

October 01, 2025

Mint New Delhi

Oil giant IOC eyes green shift

Indian Oil Corp. Ltd (IOC) is navigating choppy waters as nearterm business conditions remain uncertain amid oil price volatility, tariffs, exchange rate weakness, and geopolitical disturbances.

time to read

2 mins

October 01, 2025

Mint New Delhi

Mint New Delhi

April-August fiscal gap rises to ₹5.98 tn

India's fiscal deficit rose in the first five months of 2025-26, as compared with the same period last year, due to higher government capital expenditure while net tax revenue declined.

time to read

2 mins

October 01, 2025

Mint New Delhi

Mint New Delhi

TaMo aims to drive down Iveco costs, open new roads

Analysts questioned the rationale of buying the Italian firm that was facing growth hurdles

time to read

2 mins

October 01, 2025

Mint New Delhi

Mint New Delhi

Nestlé India inks MoU with govt to push food sector investment

FMCG major Nestlé India on Tuesday said it has signed a memorandum of understanding (MoU) with the government to expedite investments in the food industry.

time to read

1 min

October 01, 2025

Mint New Delhi

Reits revolution: own a slice of malls, offices with just ₹500

Think mutual funds, but for real estate. That's how Pratik Dantara, executive committee member of the Indian Reits Association, explains Real Estate Investment Trusts (Reits)-a growing investment avenue giving retail investors exposure to office parks, malls, and other commercial properties.

time to read

2 mins

October 01, 2025

Mint New Delhi

How Indians get a passport to global markets via GIFT

Global access GIFT City outbound funds offer international exposure

time to read

2 mins

October 01, 2025

Mint New Delhi

Poonawalla eyes RCB at $1-1.2 bn valuation

Adar Poonawalla, owner of the vaccine maker Serum Institute, is evaluating a deal to buy the Indian Premier League team Royal Challengers Bengaluru at a valuation of up to $1-1.2 billion, a person directly aware of the development said.

time to read

1 mins

October 01, 2025

Mint New Delhi

Demand for offices stays strong: C&W

Net leasing of office spaces increased 35% across eight major cities during the JulySeptember period to 16.25 million sq. ft on better demand from domestic and overseas companies, according to Cushman & Wakefield (C&W).

time to read

1 min

October 01, 2025

Listen

Translate

Share

-
+

Change font size